Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Common Equity (2016 - 2025)

Prestige Consumer Healthcare has reported Common Equity over the past 16 years, most recently at $1.8 billion for Q4 2025.

  • For Q4 2025, Common Equity rose 2.29% year-over-year to $1.8 billion; the TTM value through Dec 2025 reached $1.8 billion, up 2.29%, while the annual FY2025 figure was $1.8 billion, 10.86% up from the prior year.
  • Common Equity for Q4 2025 was $1.8 billion at Prestige Consumer Healthcare, roughly flat from $1.8 billion in the prior quarter.
  • Over five years, Common Equity peaked at $1.9 billion in Q2 2025 and troughed at $1.4 billion in Q1 2021.
  • A 5-year average of $1.6 billion and a median of $1.6 billion in 2022 define the central range for Common Equity.
  • Biggest five-year swings in Common Equity: rose 16.15% in 2022 and later decreased 8.27% in 2023.
  • Year by year, Common Equity stood at $1.5 billion in 2021, then increased by 11.1% to $1.7 billion in 2022, then fell by 5.12% to $1.6 billion in 2023, then grew by 11.74% to $1.8 billion in 2024, then rose by 2.29% to $1.8 billion in 2025.
  • Business Quant data shows Common Equity for PBH at $1.8 billion in Q4 2025, $1.8 billion in Q3 2025, and $1.9 billion in Q2 2025.